Gil D. Hoftman

Dr. Gil D. Hoftman


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in Biological Psychiatry
Verified
Journal Article
Open access
LHLeanna M. Hernandez
Leanna M. Hernandez
MKMinsoo Kim
Minsoo Kim
GHGil D. Hoftman
Gil D. Hoftman
JHJillian R. Haney
Jillian R. Haney
LTLuis de la Torre-Ubieta
Luis de la Torre-Ubieta
MGMichael J. Gandal
Michael J. Gandal
Over the past decade, large-scale genetic studies have successfully identified hundreds of genetic variants robustly associated with risk for psychiatric disorders. However, mechanistic insight -- and clinical translation -- continues to lag the pace of risk variant identification, hindered by the sheer number of targets, their predominant non-coding localization, as well as pervasive pleiotropy and incomplete penetrance. Successful next steps require identification of ‘causal’ genetic variants and their proximal biological consequences; placing variants within biologically-defined functional contexts, reflecting specific molecular pathways, cell-types, circuits, and developmental windows; and characterizing the downstream, convergent neurobiological impact of polygenicity within an individual. Here, we discuss opportunities and challenges of high-throughput transcriptomic profiling in human brain, and how transcriptomics can help pinpoint mechanisms underlying genetic risk for psychiatric disorders at a scale necessary to tackle daunting levels of polygenicity. These include transcriptome-wide association studies (TWAS) and related approaches for candidate risk gene prioritization through integration of GWAS with expression quantitative trait loci (eQTL). We outline transcriptomic results informing our understanding of the brain-level molecular pathology of psychiatric disorders, including autism (ASD), bipolar disorder (BD), major depression (MDD), and schizophrenia (SCZ). Finally, we discuss systems-level approaches for integration of distinct genetic, genomic and phenotypic levels, including combining spatially-resolved gene expression and human neuroimaging maps. Results highlight the importance of understanding gene expression (dys)regulation across human brain development as a major contributor to psychiatric disease pathogenesis, from common variants acting as expression quantitative trait loci (eQTL) to rare variants enriched for gene expression regulatory pathways.

14 November 2023 in Psychiatry Research
Verified
Journal Article
Closed access
MLMichael K. Leuchter
Michael K. Leuchter
CCCole Citrenbaum
Cole Citrenbaum
AWAndrew C. Wilson
Andrew C. Wilson
TTTristan D. Tibbe
Tristan D. Tibbe
NJNicholas James Jackson
Nicholas James Jackson
ALAndrew F. Leuchter
Andrew F. Leuchter

7 December 2020 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
GHGil D. Hoftman
Gil D. Hoftman
HBH Holly Bazmi
H Holly Bazmi
ACAndrew J Ciesielski
Andrew J Ciesielski
LDLiban A Dinka
Liban A Dinka
KCKehui Chen
Kehui Chen
DLDavid A Lewis
David A Lewis
Visuospatial working memory (vsWM) requires information transfer among multiple cortical regions, from primary visual (V1) to prefrontal (PFC) cortices. This information is conveyed via layer 3 glutamatergic neurons whose activity is regulated by gamma-aminobutyric acid (GABA)ergic interneurons. In layer 3 of adult human neocortex, molecular markers of glutamate neurotransmission were lowest in V1 and highest in PFC, whereas GABA markers had the reverse pattern. Here, we asked if these opposite V1–visual association cortex (V2)–posterior parietal cortex (PPC)–PFC gradients across the vsWM network are present in layer 3 of monkey neocortex, when they are established during postnatal development, and if they are specific to this layer. We quantified transcript levels of glutamate and GABA markers in layers 3 and 6 of four vsWM cortical regions in a postnatal developmental series of 30 macaque monkeys. In adult monkeys, glutamate transcript levels in layer 3 increased across V1–V2–PPC–PFC regions, whereas GABA transcripts showed the opposite V1–V2–PPC–PFC gradient. Glutamate transcripts established adult-like expression patterns earlier during postnatal development than GABA transcripts. These V1–V2–PPC–PFC gradients and developmental patterns were less evident in layer 6. These findings demonstrate that expression of glutamate and GABA transcripts differs across cortical regions and layers during postnatal development, revealing potential molecular substrates for vsWM functional maturation.

21 September 2024 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
RTReza Tadayonnejad
Reza Tadayonnejad
JCJuliana Corlier
Juliana Corlier
TVThomas E. Valles
Thomas E. Valles
CCCole Citrenbaum
Cole Citrenbaum
CMCole Matthews
Cole Matthews
ALAndrew F. Leuchter
Andrew F. Leuchter

14 February 2026 in Transcranial Magnetic Stimulation
Verified
Journal Article
Open access
EEEvan H. Einstein
Evan H. Einstein
TVThomas E. Valles
Thomas E. Valles
CCCole Citrenbaum
Cole Citrenbaum
JCJuliana Corlier
Juliana Corlier
Raghav GuptaRaghav Gupta
Raghav Gupta
ALAndrew F. Leuchter
Andrew F. Leuchter

5 September 2024 in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Verified
Journal Article
Closed access
HFHoki Fung
Hoki Fung
GHGil D. Hoftman
Gil D. Hoftman